Genelabs Technologies Reports Financial Results for Q3 and 1st 9 Months of 2006
13th Nov 2006, 17:24 GMT
Genelabs Technologies reported revenues of $3.6 mln and a net loss of $0.6 mln, or $0.03 per share, for Q3 ended 9/30/2006.
Genelabs Technologies Reports Financial Results for Q3 and 1st 9 Months of 2006 related news:
- Adherex Reports Q3 2006 Financial Results — Radiology News from StratCenter.com
- BioSante Pharmaceuticals Reports Q3 2006 Financial Results And Reviews Bio-E-Gel Marketing Agreement — Operations-Related News from StratCenter.com
- CytRx Reports Q3 Financial Results — Bio-Technology News from StratCenter.com
- JMAR Technologies Reports Q3 2006 Results — StratWire - Business of Healthcare NewsFeed
- Opexa Reports Q3 Financial Results — Nephrology/ Dialysis News from StratCenter.com
- InSite Vision Reports Q3 2006 Financial Results — Operations-Related News from StratCenter.com
- Favrille Reports Q3 2006 Financial Results — StratWire - Business of Healthcare NewsFeed
- IDM Pharma Reports Q3 2006 Financial Results — Pharmaceuticals News from StratCenter.com
- Antares Pharma Reports Q3 2006 Financial Results — Pharmaceuticals News from StratCenter.com
- Nymox Reports Q3 2006 Financial Results — Pharmaceuticals News from StratCenter.com
Latest news from Partnerships/ Joint Ventures News from StratCenter.com:
- Local firm forms foundation for women's sexual health
- Lifeline Therapeutics to Recognize Previously Deferred Retail Chain Revenue
- Interim Data on Use of tgAAC94 in the Treatment of Inflammatory Arthritis Presented at the American College of Rheumatology Meeting
- NextGen Healthcare and Primetime Medical Software Partner to Enhance Communications Between Doctors and Patients
- 3 Keane Executives to Present at the 2006 Gartner Healthcare Summit in San Diego
- Yaupon Therapeutics Closes $4 mln Financing
- CareTech Solutions and Yampa Valley Med Cntr Announce New IT Outsourcing Agreement
- Frost & Sullivan Honors Covance for Superior Market Leadership, Creating Enhanced Customer Value in the North American CRO Market
- Health Care Property Closes $1B Offering
- - Webcast Alert: Isis Pharmaceuticals Announces Its Analyst/Investor Webcast Presentation